>>Assuming the hem phase II trial news is good (fingers crossed, lucky rabbits foot, etc. etc.), XOMA stock price will move upward only if we attract a new analyst and/or land a deal with a major pharm company for the drug.<<
I disagree. If the news is good, people will start seeing large markets for BPI everywhere. It will be positive news for a new and lucrative indication in addition to the small market for miningo. People will be thinking, hey if it works for 2 indications, it is likely to work for more, like antibiotic resistant bacteria. But if this is the case, then the analysts will come. As will the pharms.
>>Doesn't XOMA know the Phase II results at this point? Don't you think they are showing the results to the bvig pharm companies trying to land a deal?<<
Yes, they know. If the results are good, I am sure they are currently in negotiations. Sometimes these negotiations can take time, but my guess is it won't be too much longer. Everyone would like to see an effective hem trauma drug on the market. |
